Matches in Nanopublications for { ?s ?p "[EMSY amplification was seen in 52/285 (18%) high grade papillary serous carcinomas, 4/27 (15%) high grade endometrioid carcinomas, 3/38 (8%) clear cell carcinomas, and 3/10 (30%) undifferentiated carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP760821.RApZGM0ZHVjokgyAp3gw-eyhR0mOb5whLMgAc0Qp9dosc130_assertion description "[EMSY amplification was seen in 52/285 (18%) high grade papillary serous carcinomas, 4/27 (15%) high grade endometrioid carcinomas, 3/38 (8%) clear cell carcinomas, and 3/10 (30%) undifferentiated carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760821.RApZGM0ZHVjokgyAp3gw-eyhR0mOb5whLMgAc0Qp9dosc130_provenance.
- NP860708.RAQcjd-jTJwKcFUBgEyX0sEXu2ZsuiIFdC57cCAl-9xZE130_assertion description "[EMSY amplification was seen in 52/285 (18%) high grade papillary serous carcinomas, 4/27 (15%) high grade endometrioid carcinomas, 3/38 (8%) clear cell carcinomas, and 3/10 (30%) undifferentiated carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860708.RAQcjd-jTJwKcFUBgEyX0sEXu2ZsuiIFdC57cCAl-9xZE130_provenance.
- NP725005.RA6BY43zHPjBP9r_wb9m3xvtA2irVWB5XPj2t8IGi-pnE130_assertion description "[EMSY amplification was seen in 52/285 (18%) high grade papillary serous carcinomas, 4/27 (15%) high grade endometrioid carcinomas, 3/38 (8%) clear cell carcinomas, and 3/10 (30%) undifferentiated carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP725005.RA6BY43zHPjBP9r_wb9m3xvtA2irVWB5XPj2t8IGi-pnE130_provenance.
- NP518694.RAlNzIvV0dayJ9bnMNUT31EAGkacqKysSaKLk8q4OPewE130_assertion description "[EMSY amplification was seen in 52/285 (18%) high grade papillary serous carcinomas, 4/27 (15%) high grade endometrioid carcinomas, 3/38 (8%) clear cell carcinomas, and 3/10 (30%) undifferentiated carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518694.RAlNzIvV0dayJ9bnMNUT31EAGkacqKysSaKLk8q4OPewE130_provenance.
- NP924911.RAFl2cV6fpz734oDSWbrRu3t2ibRiTcL0xDUps7shd2sM130_assertion description "[EMSY amplification was seen in 52/285 (18%) high grade papillary serous carcinomas, 4/27 (15%) high grade endometrioid carcinomas, 3/38 (8%) clear cell carcinomas, and 3/10 (30%) undifferentiated carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924911.RAFl2cV6fpz734oDSWbrRu3t2ibRiTcL0xDUps7shd2sM130_provenance.
- NP924912.RAGIusY_fkpKvALQmXmSrUbGG83RGesm79OVodZj6b6WM130_assertion description "[EMSY amplification was seen in 52/285 (18%) high grade papillary serous carcinomas, 4/27 (15%) high grade endometrioid carcinomas, 3/38 (8%) clear cell carcinomas, and 3/10 (30%) undifferentiated carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924912.RAGIusY_fkpKvALQmXmSrUbGG83RGesm79OVodZj6b6WM130_provenance.
- NP518698.RAw6Pfr00bUaM77bQxwmrt3553j0ZB5XBoHoK7EqQpiL8130_assertion description "[EMSY amplification was seen in 52/285 (18%) high grade papillary serous carcinomas, 4/27 (15%) high grade endometrioid carcinomas, 3/38 (8%) clear cell carcinomas, and 3/10 (30%) undifferentiated carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518698.RAw6Pfr00bUaM77bQxwmrt3553j0ZB5XBoHoK7EqQpiL8130_provenance.